// App-Quantinova.ai

BSH2020‐EP‐074 : Is the all‐oral DEVEC metronomic schedule a better alternative to infusional chemotherapy protocols in elderly with peripheral T‐cell lymphoma?

Researchers

Presenter

  • M. C. Cox

Principal Investigators

  • S. Pelliccia

  • M. Banchi

  • A. Di Napoli

  • L. Marcheselli

  • C. Patti

  • P. Anticoli-Borza

  • R. Battistini

  • A. Sivashangar

  • F. Di Gregorio

  • G. Bocci

Medical Centers

  • Haematology, Kings College Hospital, London,

  • Haematology, Azienda Ospedaliera‐Universitaria Sant'Andrea, Rome

  • clinical and experimental medicine,university of Pisa,Pisa,Italy

  • Experimental Medicine, Azienda Ospedaliera‐Universitaria Sant'Andrea, Rome

  • Oncology, Modena University, Modena

  • Haematology, Azienda Ospedaliera Cervello, Palermo

  • Hematology - Azienda Ospedaliera San Giovanni,Roma,I

  • Gastroenterology, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy

  • Haematology, Kings College Hospital, London,

  • Hematology, Azienda Ospedaliera S. Andrea, Rome, Italy

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Peripheral T-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Vinorelbine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved